Limited expression of Fas and Fas ligand in fetal nucleated erythrocytes isolated from first trimester maternal blood

Prenatal Diagnosis

Volumn 22, Issue 13, 2002, Pages 1213-1218

  Sohda, Satoshi ^a   Samura, Osamu ^a   Johnson, Kirby L ^a   Falco, Vincent M ^a   Elmes, R Sarah ^a   Bianchi, Diana W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; FACS; Fas; Fas ligand; Fetal cells in maternal blood

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE; FEMALE; FETUS; FETUS CELL; FIRST TRIMESTER PREGNANCY; FLUORESCENCE IN SITU HYBRIDIZATION; GENDER IDENTITY; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERNAL BLOOD; MATERNAL PLASMA; NORMAL HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; X CHROMOSOME; Y CHROMOSOME;

ADULT; ANTIGENS, CD95; APOPTOSIS; DNA; DNA FRAGMENTATION; ERYTHROBLASTS; FAS LIGAND PROTEIN; FEMALE; FETAL BLOOD; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MEMBRANE GLYCOPROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0036933494     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.480     Document Type: Article

References (39)

1. Bianchi DW. 1998. Fetal DNA in maternal plasma: The plot thickens and the placental barrier thins. Am J Hum Genet 62: 763-764.
2. Bianchi DW. 1999. Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis. Br J Haematol 105: 574-583.
3. Bianchi DW, Pertl B. 2001. Fetal DNA in maternal plasma: Emerging clinical applications. Obstet Gynecol 98: 483-490.
4. Bianchi DW, Flint AF, Pizzimenti MF, et al. 1990. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A 87: 3279-3283.
5. Bianchi DW, Klinger KW, Vadnais TJ, et al. 1996. Development of a model system to compare cell separation methods for the isolation of fetal cells from maternal blood. Prenat Diagn 16: 289-298.
6. Bianchi DW, Williams JM, Sullivan LM, et al. 1997. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61: 822-829.
7. De Maria R, Boirivant M, Cifone MG, et al. 1996. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest 97: 316-322.
8. DeMaria MA, Zheng YL, Zhen D, et al. 1996. Improved fetal nucleated erythrocyte sorting purity using intracellular antifetal hemoglobin and Hoechst 33342. Cytometry 25: 37-45.
9. Goldberg JD. 1997. Fetal cells in maternal circulation, progress in analysis of a rare event. Am J Hum Genet 61: 806-809.
10. Hamada H, Arinami T, Kubo T, et al. 1993. Fetal nucleated cells in maternal peripheral blood: Frequency and relationship to gestational age. Hum Genet 91: 427-432.
11. Itoh N, Yonehara S, Ishii A, et al. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
12. Kawane K, Fukuyama H, Kondoh G, et al. 2001. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292: 1546-1549.
13. Kolialexi A, Tsangaris GT, Antsaklis A, et al. 2001a. Apoptosis in maternal peripheral blood during pregnancy. Fetal Diagn Ther 16: 32-37.
14. Kolialexi A, Tsangaris GT, Mavrou A, et al. 2001b. Use of Annexin V antibody to identify apoptotic cells during pregnancy. Ann NY Acad Sci 945: 145-150.
15. Lewis DE, Schober W, Murrell S, et al. 1996. Rare event selection of fetal nucleated erythrocytes in maternal blood by flow cytometry. Cytometry 23: 218-227.
16. Liles WC, Kiener PA, Ledbetter JA, et al. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184: 429-440.
17. Lo YM, Patel P, Wainscoat JS, et al. 1989. Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet 2: 1363-1365.
18. Lo YM, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
19. Lo YM, Tein MS, Lau TK, et al. 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775.
20. Lo YM, Zhang J, Leung TN, et al. 1999. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64: 218-224.
21. Martin WL, Durrant LG, Liu DT, et al. 1998. Non-invasive fetal cell isolation from maternal blood. Br J Obstet Gynaecol 105: 576-583.
22. Nagata S. 1997. Apoptosis by death factor. Cell 88: 355-365.
23. Nagata S, Goldstein P. 1995. The Fas death factor. Science 267: 1449-1456.
24. Ober C. 1998. HLA and pregnancy: The paradox of the fetal allograft. Am J Hum Genet 62: 1-5.
25. Reading JP, Huffman JL, Wu JC, et al. 1995. Nucleated erythrocytes in maternal blood: Quantity and quality of fetal cells in enriched populations. Hum Reprod 10: 2510-2515.
26. Runic R, Lockwood CJ, LaChapelle L, et al. 1998. Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab 83: 660-666.
27. Samura O, Sekizawa A, Zhen DK, et al. 2000. Comparison of fetal cell recovery from maternal blood using high density gradient for initial separation step, 1.090 vs. 1.119. Prenat Diagn 20: 281-286.
28. Sekizawa A, Samura O, Zhen DK, et al. 2000. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 20: 886-889.
29. Simpson JL, Elias S. 1993. Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. JAMA 270: 2357-2361.
30. Sohda S, Arinami T, Hamada H, et al. 1997. The proportion of fetal nucleated red blood cells in maternal blood: Estimation by FACS analysis. Prenat Diagn 17: 743-752.
31. Suda T, Tanaka M, Miwa K, et al. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 157: 3918-3924.
32. Takabayashi H, Kuwabara S, Ukita T, et al. 1995. Development of non-invasive fetal DNA diagnosis from maternal blood. Prenat Diagn 15: 74-77.
33. Takahashi T, Tanaka M, Inazawa J, et al. 1994. Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol 6: 1567-1574.
34. Tanaka M, Itai T, Adachi M, et al. 1998. Downregulation of Fas ligand by shedding. Nat Med 4: 31-36.
35. Tanaka M, Suda T, Haze K, et al. 1996. Fas ligand in human serum. Nat Med 2: 317-322.
36. Wang JY, Zhen DK, Falco VM, et al. 2000. Fetal nucleated erythrocyte recovery: Fluorescence activated cell sorting-based positive selection using anti-gamma globin versus magnetic activated cell sorting using anti-CD45 depletion and anti-gamma globin positive selection. Cytometry 39: 224-230.
37. Zermati Y, Garrido C, Amsellem S, et al. 2001. Caspase activation is required for terminal erythroid differentiation. J Exp Med 193: 247-254.
38. Zhen DK, Wang JY, Falco VM, et al. 1998. Poly-FISH: A technique of repeated hybridizations that improves cytogenetic analysis of fetal cells in maternal blood. Prenat Diagn 18: 1181-1185.
39. Zheng YL, De Maria M, Zhen D, et al. 1995. Flow sorting of fetal erythroblasts using intracytoplasmic anti-fetal haemoglobin: Preliminary observations on maternal samples. Prenat Diagn 15: 897-905.